Dobutamine Hydrochloride Injection Shortage: Current Status and Manufacturer Availability

What’s in Shortage

Dobutamine Hydrochloride Injection (Brand Name: DOBUTAMINE HYDROCHLORIDE IN DEXTROSE) is currently listed in a shortage status by the FDA. This medication is an injection used within the Cardiovascular, Pediatric, and Renal therapeutic categories.

Which Manufacturers Are Affected

According to the latest data, the following manufacturer is listed with available supply for specific presentations:

• Baxter Healthcare
  • Status: Available
  • Presentations:
    • Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, 100 mg/100 mL (NDC 0338-1073-02)
    • Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, 200 mg/100 mL (NDC 0338-1075-02)
    • Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, 400 mg/100 mL (NDC 0338-1077-02)
  • Contact Information: 888-229-0001

Why There’s a Shortage

No specific reason for the shortage of Dobutamine Hydrochloride Injection was provided in the source data.

What Patients Should Do

Patients who rely on this medication should be aware that while the drug is in a shortage status, certain presentations remain available. We recommend the following steps:

• Consult Your Healthcare Provider: Discuss your treatment plan and any concerns regarding medication availability with your doctor.
• Speak with Your Pharmacist: Pharmacists can provide the most up-to-date information on local stock and supply chain status.
• Contact the Manufacturer: For specific questions regarding supply, you may contact Baxter Healthcare at 888-229-0001.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Patients should always consult their healthcare provider regarding medical conditions and treatment options.

Source

Information provided by the FDA Drug Shortage Database.

• Initial Posting Date: 11/06/2017
• Last Updated: 02/02/2026